Мобильная версия

Доступно журналов:

3 288

Доступно статей:

3 891 637

 

Скрыть метаданые

Автор Akiba, Tadashi
Автор Saijo, Nagahiro
Автор Miyamoto, Kengo
Автор Sakurai, Masanori
Автор Tamura, Tomohide
Автор Sasaki, Yasutsuna
Автор Eguchi, Kenji
Автор Shinkai, Tetsu
Автор Uei, Yoshio
Автор Fujiwara, Yasuhiro
Автор Nakano, Hidehiko
Автор Nakagawa, Kazuhiko
Автор Hong, Weon Seon
Дата выпуска 1987
dc.description A 63-year-old man was admitted to the National Cancer Center Hospital on December 20, 1983 for a close examination of the abnormal shadows found in chest roentgenograms. Chest radiographs showed a massive right pleural effusion, a large tumor in the right bilar region and swelling of the left hilar nodes. Transcutaneous needle biopsy revealed the tumor's cytological type to be adenocarcinoma. The clinical stage was considered to be T3N2M1 (American joint committee (AJC) stage III M1), and his performance status was 4, so he was given etoposide (VP-16) alone as the initial chemotherapy treatment. He showed a partial response upon two courses of VP-16 therapy. Subsequently, one course of cisplatin (80 mg/m<sup>2</sup>) + vindesine (3.3 mg/m<sup>2</sup>), two courses of VP-16 (80 mg/m<sup>2</sup> D1–4), five courses of cyclophosphamide (80 mg/m<sup>2</sup>) + adriamycin (50 mg/m<sup>2</sup>) + vincristine (1.4 mg/m<sup>2</sup>) and two courses of VP-16 (100 mg/m<sup>2</sup> D1, 3, 5) were administered sequentially until May 31, 1985. No radiation therapy was given and, up to March 31, 1987, no sign of recurrence had been observed.
Формат application.pdf
Издатель Oxford University Press
Копирайт © Oxford University Press
Тема VP-16
Тема Non-small cell lung cancer
Тема Case Reports
Название A Case of Adenocarcinoma of the Lung which Was Successfully Treated by Chemotherapy with Patient Survival without Recurrence for More Than Three Years
Тип case-report
Electronic ISSN 1465-3621
Print ISSN 0368-2811
Журнал Japanese Journal of Clinical Oncology
Том 17
Первая страница 165
Последняя страница 172
Аффилиация Akiba Tadashi; Department of Internal Medicine, National Cancer Center Hospital
Аффилиация Saijo Nagahiro; Department of Internal Medicine, National Cancer Center Hospital
Аффилиация Miyamoto Kengo; Department of Internal Medicine, National Cancer Center Hospital
Аффилиация Sakurai Masanori; Department of Internal Medicine, National Cancer Center Hospital
Аффилиация Tamura Tomohide; Department of Internal Medicine, National Cancer Center Hospital
Аффилиация Sasaki Yasutsuna; Department of Internal Medicine, National Cancer Center Hospital
Аффилиация Eguchi Kenji; Department of Internal Medicine, National Cancer Center Hospital
Аффилиация Shinkai Tetsu; Department of Internal Medicine, National Cancer Center Hospital
Аффилиация Uei Yoshio; Clinical Laboratory, National Cancer Center Hospital
Аффилиация Fujiwara Yasuhiro; Pharmacology Division, National Cancer Center Research Institute
Аффилиация Nakano Hidehiko; Pharmacology Division, National Cancer Center Research Institute
Аффилиация Nakagawa Kazuhiko; Pharmacology Division, National Cancer Center Research Institute
Аффилиация Hong Weon Seon; Pharmacology Division, National Cancer Center Research Institute
Выпуск 2

Скрыть метаданые